Potential for bleeding with the new beta-lactam antibiotics

Insights

Certain beta-lactam antibiotics can disrupt blood clotting. Cephalosporins with methylthiotetrazole may cause hypoprothrombinemia, while others with alpha-carboxyl groups can impair platelet function, increasing bleeding risk.

Area of Science:

  • Pharmacology
  • Hematology
  • Internal Medicine

Background:

  • Beta-lactam antibiotics are widely used, but some can interfere with hemostasis.
  • Specific structural features of beta-lactams are associated with distinct hemostatic defects.

Purpose of the Study:

  • To review the hemostatic complications associated with various beta-lactam antibiotics.
  • To identify the specific antibiotic structures linked to hypoprothrombinemia and impaired platelet function.

Main Methods:

  • Literature review of clinical studies and case reports on beta-lactam antibiotic-induced hemostatic abnormalities.
  • Analysis of antibiotic structures and their correlation with observed bleeding risks.

Main Results:

  • Cephalosporins with methylthiotetrazole substitution (e.g., cefamandole, moxalactam) frequently cause hypoprothrombinemia (4-68% incidence), especially in high-risk patients.
  • Beta-lactams with alpha-carboxyl substitution (e.g., moxalactam, carbenicillin) impair platelet function, prolonging bleeding time.
  • Acylureidopenicillins show less frequent and milder platelet dysfunction.

Conclusions:

  • Hypoprothrombinemia from methylthiotetrazole-containing cephalosporins requires fresh frozen plasma for treatment.
  • Platelet dysfunction necessitates platelet concentrate transfusions to manage serious hemorrhage.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...